loadpatents
name:-0.043807029724121
name:-0.029870986938477
name:-0.0026869773864746
Song; Jiangao Patent Filings

Song; Jiangao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Song; Jiangao.The latest application filed is for "cb-0406 choline salt".

Company Profile
1.30.40
  • Song; Jiangao - Sunnyvale CA
  • Song; Jiangao - Hayward CA
  • - Sunnyvale CA US
  • Song; Jiangao - Cupertino CA
  • Song, Jiangao - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CB-0406 choline salt
App 20210355066 - Boerrigter; Stephan X.M. ;   et al.
2021-11-18
CB-0406 tromethamine salt
App 20210355065 - Boerrigter; Stephan X.M. ;   et al.
2021-11-18
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 9,925,189 - Chen , et al. March 27, 2
2018-03-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20180021335 - Chen; Xin ;   et al.
2018-01-25
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 9,737,537 - Chen , et al. August 22, 2
2017-08-22
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20170105993 - Chen; Xin ;   et al.
2017-04-20
Bicyclic agonists of GPR131 and uses thereof
Grant 9,593,109 - Song , et al. March 14, 2
2017-03-14
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
Grant 9,150,567 - Song , et al. October 6, 2
2015-10-06
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20150239881 - Chen; Xin ;   et al.
2015-08-27
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts
App 20150197518 - Song; Jiangao ;   et al.
2015-07-16
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 8,975,258 - Chen , et al. March 10, 2
2015-03-10
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 08921350 -
2014-12-30
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 8,921,350 - Chen , et al. December 30, 2
2014-12-30
DCC mediated coupling for halofenate manufacture
Grant 8,912,356 - Song December 16, 2
2014-12-16
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 8,846,675 - Ma , et al. September 30, 2
2014-09-30
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
Grant 8,815,886 - Song , et al. August 26, 2
2014-08-26
DCC Mediated Coupling for Halofenate Manufacture
App 20140206892 - Song; Jiangao
2014-07-24
Gpr120 Receptor Agonists And Uses Thereof
App 20140121246 - Shi; Dong Fang ;   et al.
2014-05-01
Agonists of GPR131 and uses thereof
Grant 8,703,776 - Novack , et al. April 22, 2
2014-04-22
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts
App 20140038971 - SONG; Jiangao ;   et al.
2014-02-06
GPR120 receptor agonists and uses thereof
Grant 8,598,374 - Shi , et al. December 3, 2
2013-12-03
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20130281691 - Chen; Xin ;   et al.
2013-10-24
GPR120 receptor agonists and uses thereof
Grant 8,476,308 - Shi , et al. July 2, 2
2013-07-02
Gpr120 Receptor Agonists And Uses Thereof
App 20130131351 - Shi; Dong Fang ;   et al.
2013-05-23
Gpr120 Receptor Agonists And Uses Thereof
App 20130109734 - Shi; Dong Fang ;   et al.
2013-05-02
Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
Grant 8,410,127 - Song , et al. April 2, 2
2013-04-02
Bicyclic Agonists Of Gpr131 And Uses Thereof
App 20130059845 - SONG; Jiangao ;   et al.
2013-03-07
Agonists Of Gpr131 And Uses Thereof
App 20130059856 - Novack; Aaron Robert ;   et al.
2013-03-07
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20120322804 - Ma; Jingyuan ;   et al.
2012-12-20
GPR120 receptor agonists and uses thereof
Grant 8,309,600 - Shi , et al. November 13, 2
2012-11-13
GPR120 receptor agonists and uses thereof
Grant 8,299,117 - Shi , et al. October 30, 2
2012-10-30
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 8,288,384 - Chen , et al. October 16, 2
2012-10-16
2,4-disubsituted thiazoles and pharmaceutical compositions thereof
Grant 8,227,495 - Chen , et al. July 24, 2
2012-07-24
Aryl Gpr119 Agonists And Uses Thereof
App 20120184572 - Song; Jiangao ;   et al.
2012-07-19
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
Grant 8,183,381 - Ma , et al. May 22, 2
2012-05-22
Preparation Of 5-ethyl-2--pyrimidine
App 20110313160 - Chen; Xin ;   et al.
2011-12-22
Gpr120 Receptor Agonists And Uses Thereof
App 20110313003 - Shi; Dong Fang ;   et al.
2011-12-22
Aryl Gpr119 Agonists And Uses Thereof
App 20110294836 - Song; Jiangao ;   et al.
2011-12-01
Substituted Tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine Salts
App 20110152270 - Song; Jiangao ;   et al.
2011-06-23
Aryl Gpr120 Receptor Agonists And Uses Thereof
App 20100216827 - Ma; Jingyuan ;   et al.
2010-08-26
Gpr120 Receptor Agonists And Uses Thereof
App 20100190831 - Shi; Dong Fang ;   et al.
2010-07-29
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20100130511 - CHEN; XIN ;   et al.
2010-05-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20100087465 - Chen; Xin ;   et al.
2010-04-08
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-- yl}-pyrimidine
Grant 7,638,541 - Chen , et al. December 29, 2
2009-12-29
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
Grant 7,629,375 - Wang , et al. December 8, 2
2009-12-08
Spiro derivatives as lipoxygenase inhibitors
Grant 7,576,094 - Chu , et al. August 18, 2
2009-08-18
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20090137590 - Ma; Jingyuan ;   et al.
2009-05-28
Chroman derivatives
Grant 7,514,461 - Wang , et al. April 7, 2
2009-04-07
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders
App 20090054475 - Chen; Xin ;   et al.
2009-02-26
7,8-bicycloalkyl-chroman derivatives
Grant 7,470,798 - Wang , et al. December 30, 2
2008-12-30
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
App 20060178356 - Wang; Bing ;   et al.
2006-08-10
Spiro derivatives as lipoxygenase inhibitors
App 20060128790 - Chu; Daniel T.W. ;   et al.
2006-06-15
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
App 20050142155 - Wang, Bing ;   et al.
2005-06-30
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
App 20050113416 - Wang, Bing ;   et al.
2005-05-26
7,8-Bicycloalkyl-chroman derivatives
App 20050065149 - Wang, Bing ;   et al.
2005-03-24
Chroman derivatives
App 20050065150 - Wang, Bing ;   et al.
2005-03-24
Furanone derivatives
Grant 6,667,330 - Wang , et al. December 23, 2
2003-12-23
Furanone derivatives
App 20030176361 - Wang, Bing ;   et al.
2003-09-18
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
App 20030073712 - Wang, Bing ;   et al.
2003-04-17
Pyruvate derivatives
App 20030013847 - Wang, Bing ;   et al.
2003-01-16
Pyruvate derivatives
App 20030013656 - Wang, Bing ;   et al.
2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed